10 July 2019

nScrypt Partners with Geneva to Test Bioprinter

Orlando, FL-based nScrypt has partnered with the U.S. Military, the Uniformed Services University 4D Bio³ Program, RoosterBio, Inc, and Geneva to move bioprinting out of sterile biology laboratories to forward-deployed military positions. For this project, nScrypt has customized its BioAssembly Tool (BAT) bioprinter, which won the 2003 R&D 100 award and is scheduled to travel to the International Space Station in July 2019, and created a light weight and ruggedized model, shrouding it in a protective local environment for bioprinting in challenging conditions.

This project is a step towards bringing next-generation critical care close to the warfighter. Bioprinting a variety of wound-healing biologics, bandages, stents, and bandage/biosensors, on demand and at or near the point-of-care, is an example that is expected to improve healing and survival rates of the warfighter.

To learn more about this partnership, read the full press release here.